BiomX Inc. (PHGE) Q1 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello, and welcome to the Biomics first quarter 2024 financial results. If anyone should require operator assistance, please press star zero on your telephone keypad. A question and answer session will follow the formal presentation. You may be placed into question queue at any time by pressing star one. As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to CFO Avi Gabay. Please go ahead, Avi. Thank you and welcome to the Biomix first quarter 2024 financial results and corporate update conference call. The press release became available just after 6.30 a.m. Eastern time today and can be found on our website at www.biomix.com. A replay of this call will also be available on the investor section of our website. Before we begin, I'd like to review the safe harbor provision. All statements on this call that are not factual historical statement may be deemed forward-looking statements. For instance, we're using forward-looking statements when we discuss in the conference call the sufficiency of the combined company's financing, potential stockholder approval of certain matters related to the securities issued and related matters in connection with the adaptive phase therapeutics or APT merger, potential market opportunities, the ability to drive value for stockholders, the design, recruitment, aim, expected timing, and interim and final results of our preclinical and clinical trial, the regulatory process and discussion with the FDA, the potential benefits and commercial opportunities of our product candidate, and the potential safety and efficacy of BX004 and BX211. In addition, past and current preclinical and clinical results, as well as compassionate use, are not indicative and do not guarantee future success of our clinical t...